Cellebrite Misses ARR Target, Cuts Guidance, Swaps CEO
Cellebrite's Q2 ARR fell short of projections as the firm lowered annual outlook and replaced its chief executive.
Key points
- Cellebrite's Q2 ARR was $507.8 million, missing the low end of its $510-$513 million projection.
- The company cut full-year ARR guidance by $15 million and replaced CEO Tom Hogan with Shiv Ramji.
- Cellebrite stock fell 29% to $10.80 on August 13, 2026, following the earnings announcement.
Cellebrite DI Ltd. (NASDAQ: CLBT) reported second-quarter results on August 13, 2026, that fell below internal expectations. The company disclosed total Annual Recurring Revenue (ARR) of $507.8 million, a figure that missed the lower bound of its previously projected range of $510 million to $513 million. This shortfall highlighted specific operational headwinds affecting the firm’s cloud technology division.
Simultaneously with the earnings release, Cellebite announced the immediate replacement of CEO Tom Hogan with Shiv Ramji. The firm also reduced its full-year ARR guidance by approximately $15 million at the midpoint. Management attributed the revenue delay to a foreign entity permit requirement applied to cloud technology, which stalled the closing of certain key deals.
Market reaction to guidance cut
The stock market responded sharply to the combination of missed targets and leadership turnover. On August 13, 2026, Cellebrite shares declined by $4.45 per share, representing a 29% drop. The stock closed the trading day at $10.80 per share, reflecting investor concerns over the company’s near-term revenue trajectory and strategic direction.
Legal scrutiny of disclosures
According to The Globe and Mail, the law firm Kaplan Fox & Kilsheimer LLP has initiated an investigation into potential securities violations related to these events. The firm is reviewing whether the company’s prior statements regarding ARR projections and deal closures were accurate and compliant with regulatory standards.
Kaplan Fox is encouraging investors who suffered losses during the relevant period to contact the firm. The legal team is assessing claims based on the August 13 announcement, where the company simultaneously revealed the ARR miss, the guidance reduction, and the abrupt CEO transition.
